Archives of Gynecology and Obstetrics

, Volume 271, Issue 4, pp 316–319 | Cite as

Small-cell carcinoma of the uterus and the vagina: experience with ten patients

  • Edgar Petru
  • C. Pasterk
  • O. Reich
  • A. Obermair
  • R. Winter
  • G. Breitenecker
Original Article



Small cell carcinomas (small-CCs) of the uterine cervix are rare and highly malignant neoplasms. Patients tend to develop distant metastasis early and thus are potential candidates for systemic therapy. We reviewed the experience with small-CCs of the uterus and vagina at two Austrian University hospitals.

Material and methods

Ten patients (median age, 50 years; range, 18–92) with small-CC of the cervix (n=7), uterine corpus (n=2), and the vagina (n=1) were treated at the two centers between 1988 and 1998. Eight patients underwent radical surgery, 7 of whom also received chemotherapy. Two additional patients underwent primary radiotherapy.


All Pap smears were suspicious for cervical malignancy. The median survival was 12 months (range, 6–86) and overall 5-year survival was 10%. Five of 8 surgically treated patients had lymph node involvement (62%). Of the 7 patients with small-CC of the cervix only one, who had FIGO stage IIB disease and positive pelvic nodes, survived long-term (86 months) with no evidence of disease. She had received six courses of dose-intensive platinum chemotherapy after radical surgery. All three patients with small-CC of the uterine corpus or vagina developed recurrence within the first year after diagnosis. Of the 7 patients who received chemotherapy, 5 developed progressive or recurrent disease in the paraaortic region (n=2), peritoneum (n=1), liver (n=1), or pelvis (n=1).


These results confirm the particularly unfavorable prognosis of patients with small-CC of the genital tract. The optimal treatment for these patients most probably including concurrent chemo-radiotherapy remains to be defined.


Small cell carcinoma Uterine cervix Adjuvant chemotherapy Neuroendocrine carcinoma 


  1. 1.
    Abeler V, Holm R, Nesland J, Kjorstad K (1994) Small cell carcinoma of the cervix. Cancer 73:672–677PubMedGoogle Scholar
  2. 2.
    Lewandowski G, Copeland L (1993) A potential role for intensive chemotherapy in the treatment of small cell neuroendocrine tumors of the cervix. Gynecol Oncol 48:127–131Google Scholar
  3. 3.
    O’Hanlan K, Goldberg G, Jones J, Runowicz C, Ehrlich L, Rodriguez L (1991) Adjuvant therapy for neuroendocrine small cell carcinoma of the cervix. Gynecol Oncol 43:167–172Google Scholar
  4. 4.
    Delagoge S, Pautier P, Kerbrat P, Castaigne D, Haie-Meder C, Duvilla P, Guivarch C, Goupil A, Borel C, Lhomme C (2000) Neuroendocrine small cell carcinoma of the uterine cervix: what disease? what treatment? Report of ten cases and review of the literature. Clin Oncol 12:357–362CrossRefGoogle Scholar
  5. 5.
    Perrin L, Ward B (1995) Small cell carcinoma of the cervix. Int J Gynecol Cancer 5:200–203CrossRefPubMedGoogle Scholar
  6. 6.
    Chang T, Lai C, Tseng C, Hsueh S, Huang K, Chou H (1998) Prognostic factors in surgically treated small cell cervical carcinoma followed by adjuvant chemotherapy. Cancer 83:712–718CrossRefPubMedGoogle Scholar
  7. 7.
    Maaßen V, Lampe B, Debus-Thiede G, Kindermann G (1993) Das neuroendokrine Karzinom der Cervix uteri: eine besonders aggressive Krebsform mit klinischen, diagnostischen und therapeutischen Besonderheiten. Geburtshilfe Frauenheilkd 53:448–454PubMedGoogle Scholar
  8. 8.
    Hoskins P, Wong F, Swenerton K, Pike J, Manji M, McMurtrie E, Acker B, Le Riche J (1995) Small cell carcinoma of the cervix treated with concurrent radiotherapy, cisplatin, and etoposide. Gynecol Oncol 56:218–225CrossRefPubMedGoogle Scholar
  9. 9.
    Weed J, Graff A, Shoup B, Tawfik O (2003) Small cell undifferentiated (neuroendocrine) carcinoma of the uterine cervix. J Am Coll Surg 197:44–51CrossRefPubMedGoogle Scholar
  10. 10.
    Reich O, Pickel H, Pürstner P (1996) Exfoliative cytology of invasive neuroendocrine small cell carcinoma in a cervical cytologic smear. Acta Cytol 40:980–984PubMedGoogle Scholar
  11. 11.
    Sheets E, Berman M, Hrountas C, Liao S, DiSaia P (1988) Surgically treated, early-stage neuroendocrine small-cell cervical carcinoma. Obstet Gynecol 71:10–14Google Scholar
  12. 12.
    Straughn M, Richter H, Conner M, Meleth S, Barnes M (2001) Predictors of outcome in small cell carcinoma of the cervix—a case series. Gynecol Oncol 83:216–220CrossRefPubMedGoogle Scholar
  13. 13.
    Sevin BU, Method M, Nadji M, Lu Y, Averette H (1996) Efficacy of radical hysterectomy as treatment for patients with small cell carcinoma of the cervix. Cancer 77:1489–1493CrossRefPubMedGoogle Scholar
  14. 14.
    Wagman F, Estape R, Mendez L, Cantuaria G, Mirhashemi R, Averette H, Penalver M (2000) Small cell carcinoma of the cervix: analysis and outcome of treatment modalities [abstract]. Gynecol Oncol 76:230CrossRefPubMedGoogle Scholar
  15. 15.
    Chan J, Loizzi V, Burger R, Rutgers J, Monk B (2003) Prognostic factors in neuroendocrine small cell cervical carcinoma. Cancer 97:568–574CrossRefPubMedGoogle Scholar
  16. 16.
    Yu A, Zhang P, Lou H (2002) Clinicopathologic characteristics and treatment of small cell carcinoma of the uterine cervix. Zhonghua Zhong Liu Za Zhi 24:400–403PubMedGoogle Scholar
  17. 17.
    Boruta D, Schorge J, Duska L, Crum C, Castrillon D, Sheets E (2001) Multimodality therapy in early-stage neuroendocrine carcinoma of the uterine cervix. Gynecol Oncol 81:82–87CrossRefPubMedGoogle Scholar
  18. 18.
    Sykes A, Shanks J, Davidson S (1999) Small cell carcinoma of the uterine cervix: a clinicopathological review. Int J Oncol 14:381–386PubMedGoogle Scholar
  19. 19.
    Morris M, Gershenson D, Eifel P, Silva E, Mitchell M, Burke T, Wharton T (1992) Treatment of small cell carcinoma of the cervix with cisplatin, doxorubicin, and etoposide. Gynecol Oncol 47:62–65CrossRefPubMedGoogle Scholar
  20. 20.
    Bermudez A, Vighi S, Garcia A, Sardi J (2001) Neuroendocrine carcinoma: a diagnostic and therapeutic challenge. Gynecol Oncol 82:32–39CrossRefPubMedGoogle Scholar
  21. 21.
    Kim Y, Barbuto D, Lagasse L, Karlan B (1996) Successful treatment of neuroendocrine small cell carcinoma of the cervix metastatic to the regional lymph nodes. Gynecol Oncol 62:411–414Google Scholar
  22. 22.
    Abulafia O, Sherer D (1995) Adjuvant chemotherapy in stage Ib neuroendocrine small cell carcinoma of the cervix. Acta Obstet Scand 74:740–744Google Scholar
  23. 23.
    McGarry R, Smith C, Seemayer T (1999) Treatment resistant small cell carcinoma of the cervix. Oncology 57:293–296CrossRefPubMedGoogle Scholar
  24. 24.
    Lim F, Chong S, Sethi V (1999) Small cell neuroendocrine carcinoma of the cervix with involvement of multiple pelvic nodes—a successfully treated case by multimodal approach. Gynecol Oncol 72:246–249CrossRefPubMedGoogle Scholar
  25. 25.
    Conner M, Richter H, Moran C, Hameed A, Albores-Saavedra J (2002) Small cell carcinoma of the cervix: a clinicopathologic and immunohistochemical study of 23 cases. Ann Diagn Pathol 6:345–348CrossRefPubMedGoogle Scholar
  26. 26.
    Hoskins P, Swenerton K, Pike J, Lim P, Aquino-Parsons C, Wong F, Lee N (2003) Small cell carcinoma of the cervix: fourteen years of experience at a single institution using a combined-modality regimen of involved-field irradiation and platinum-based combination chemotherapy. J Clin Oncol 21:3495–3501CrossRefPubMedGoogle Scholar
  27. 27.
    Balderston K, Tewari K, Gregory T, Berman M, Kucera P (1998) Neuroendocrine small cell uterine cervix cancer in pregnancy: long-term survival following combined therapy. Gynecol Oncol 71:128–132CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • Edgar Petru
    • 1
  • C. Pasterk
    • 2
  • O. Reich
    • 1
  • A. Obermair
    • 2
  • R. Winter
    • 1
  • G. Breitenecker
    • 2
  1. 1.Department of Obstetrics and GynecologyUniversity of GrazGrazAustria
  2. 2.Department of Obstetrics and Gynecology, Institute of PathologyUniversity of ViennaViennaAustria

Personalised recommendations